OppenheimerFunds’s QIAGEN NV QGENF Stock Holding History

OppenheimerFunds’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-982,601	Closed	-$21.4M	–	1812
2016 Q2	$21.4M	Buy	982,601 +26	+0%	+$567	0.03%	536
2016 Q1	$21.9M	Sell	982,575 -520	-0.1%	-$11.6K	0.03%	531
2015 Q4	$27.2M	Buy	983,095 +310,125	+46%	+$8.58M	0.03%	477
2015 Q3	$17.4M	Hold	672,970	–	–	0.02%	587
2015 Q2	$16.7M	Hold	672,970	–	–	0.02%	631
2015 Q1	$17M	Hold	672,970	–	–	0.02%	633
2014 Q4	$15.8M	Hold	672,970	–	–	0.02%	644
2014 Q3	$15.3M	Hold	672,970	–	–	0.02%	634
2014 Q2	$16.5M	Hold	672,970	–	–	0.02%	633
2014 Q1	$14.2M	Buy	672,970 +268,540	+66%	+$5.66M	0.02%	679
2013 Q4	$9.63M	Buy	+404,430	New	+$9.63M	0.01%	748

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

OppenheimerFunds's QGENF Position: Q3 2016 in Review

OppenheimerFunds sold out of QIAGEN NV (QGENF) in Q3 2016, closing a stake of 982,601 shares — an estimated $21.4M sold.

OppenheimerFunds first reported a position in QGENF in Q4 2013 and held it in 11 quarters. The position peaked at $27.2M in Q4 2015. 210 funds tracked by Wall St. Rank hold QGENF as of Q3 2016.

OppenheimerFunds reported no remaining QIAGEN NV position as of Q3 2016 after selling out during the quarter.
OppenheimerFunds sold 982,601 QIAGEN NV shares in Q3 2016, an estimated $21.4M.
OppenheimerFunds first reported a position in QIAGEN NV in Q4 2013 and held it in 11 quarters.
OppenheimerFunds's QIAGEN NV position peaked at $27.2M in Q4 2015.
210 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2016.

Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.